These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11359720)

  • 1. Contrast enhancement and the acute lesion in multiple sclerosis.
    Rovaris M; Filippi M
    Neuroimaging Clin N Am; 2000 Nov; 10(4):705-16 ,viii-ix. PubMed ID: 11359720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnetic resonance imaging in multiple sclerosis].
    Tourbah A; Berry I
    Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C
    J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
    Inglese M; Grossman RI; Filippi M
    J Neuroimaging; 2005; 15(4 Suppl):22S-29S. PubMed ID: 16385016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.
    McFarland HF; Frank JA; Albert PS; Smith ME; Martin R; Harris JO; Patronas N; Maloni H; McFarlin DE
    Ann Neurol; 1992 Dec; 32(6):758-66. PubMed ID: 1471866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of MRI in the diagnosis of multiple sclerosis.
    Traboulsee AL; Li DK
    Adv Neurol; 2006; 98():125-46. PubMed ID: 16400831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.
    Narayana PA; Doyle TJ; Lai D; Wolinsky JS
    Ann Neurol; 1998 Jan; 43(1):56-71. PubMed ID: 9450769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
    Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
    Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis].
    Sailer M; Fazekas F; Gass A; Kappos L; Radue EW; Rieckmann P; Toyka K; Wiendl H; Bendszus M
    Rofo; 2008 Nov; 180(11):994-1001. PubMed ID: 18937154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A; León A
    Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MRI visualization of multiple sclerosis lesions].
    Berry I; Ranjeva JP; Manelfe C; Clanet M
    Rev Neurol (Paris); 1998 Sep; 154(8-9):607-17. PubMed ID: 9809376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging advances in multiple sclerosis.
    Bakshi R
    J Neuroimaging; 2005; 15(4 Suppl):5S-9S. PubMed ID: 16385014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnetic resonance imaging in multiple sclerosis].
    Saida T
    Rinsho Shinkeigaku; 1999 Jan; 39(1):114-5. PubMed ID: 10377832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
    Zivadinov R; Leist TP
    J Neuroimaging; 2005; 15(4 Suppl):10S-21S. PubMed ID: 16385015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional MRI in multiple sclerosis.
    Filippi M; Rocca MA
    J Neuroimaging; 2007 Apr; 17 Suppl 1():3S-9S. PubMed ID: 17425727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of magnetic resonance imaging in the study of multiple sclerosis: diagnosis, prognosis and understanding disease pathophysiology.
    Filippi M; Rocca MA
    Acta Neurol Belg; 2011 Jun; 111(2):89-98. PubMed ID: 21748926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.